The EPO’s Enlarged Board of Appeal has published its much-awaited decision on G 1/22 and G 2/22 regarding the validity…
Read More
The EPO’s Enlarged Board of Appeal has published its much-awaited decision on G 1/22 and G 2/22 regarding the validity…
Read MoreIn yet another David and Goliath dispute, serial licensor easyGroup has launched legal action in the UK High Court against…
Read MoreIn today’s globalised world, counterfeit pharmaceuticals have emerged as a silent epidemic, endangering the health and lives of millions. The…
Read MoreThe UK Intellectual Property Office (UK IPO) is the first national intellectual property office to upgrade its in-house search facilities…
Read MoreWhen the UK left the EU with effect from 1 January 2021, the UK Intellectual Property Office (UK IPO) set…
Read MoreMotor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read MoreWith an estimated 4.48 billion social media users worldwide, it is unsurprising that counterfeiters, and those promoting counterfeit goods, have…
Read MoreSince the launch of ChatGPT in November 2022, the power of AI has been at the forefront of many peoples’…
Read MoreInfluencer culture is prevalent across all social media platforms, offering a relatively new and powerful marketing channel for brands. It’s…
Read MoreAccording to the IEA report ‘Emissions from Oil and Gas Operations in Net Zero Transitions’, oil and gas operations account…
Read MoreIt’s the correspondence that no one wants to receive: a cease-and-desist letter, informing the recipient that they are infringing Intellectual…
Read MoreThe European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…
Read More